Explorer
Will we get nod for vaccine's emergency use? DCGI press conference at 11 am
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
India
BREAKING NEWS: 'Lungi' Remark Sparks Rajya Sabha Uproar as John Brittas Alleges Insult to South Indians
BIG BREAKING: Rahul Gandhi Demands Amit Shah’s Resignation Over Student Protest Action
BREAKING: Amit Shah Challenges Opposition to Debate, Says Government Ready to Answer Every Question
BIG CLASH: Amit Shah Calls for Parliament Debate as Rahul Gandhi Demands Answers and Accountability
Breaking: Tata Sons Chair N Chandrasekaran Resigns; Term Continues Until February 2027, Shares Fall!
View More
Top Headlines
India
Who Are The Candidates For Ram Temple CEO's Post?
India
Activist Devendra Mahto Seeks Civil Surgeon's Nod To Return From Hospital To Ranchi Protest Site
Cities
Pitbull Attacks Couple In Patiala; Woman Suffers Deep Injuries In Shocking CCTV Footage
World
Karoline Leavitt To Step Down As White House Press Secretary
Trending News
